TP53 and colorectal cancer: To examine whether a combination of p53 activation and treatment with calcitriol may lead to an enhanced CST5 induction, we treated the colorectal cancer cell line SW480/pRTR-p53-VSV with DOX, calcitriol or both agents (Figure 5).